Clinical damage model
Factor | Relative damage rate | Lower 95% CI | Upper 95% CI | p Value |
---|---|---|---|---|
DMARDs, disease-modifying antirheumatic drugs; ESR, erythrocyte sedimentation rate; NSAIDs, non-steroidal anti-inflammatory drugs. | ||||
Sex | ||||
Female | 1 | |||
Male | 1.08 | 0.88 | 1.32 | 0.45 |
Age | 1.08 per decade | 1 | 1.16 | 0.05 |
Time in clinic | 0.66 per decade | 0.56 | 0.78 | <0.001 |
Initial ESR | 1.01 | 1 | 1.01 | <0.001 |
Tender | 1.02 per joint | 1.01 | 1.03 | 0.002 |
Swollen | 1.08 per joint | 1.05 | 1.1 | <0.001 |
Deformed joints | ||||
None (0) | 1 | |||
Low (1–4) | 2.84 | 2.1 | 3.85 | <0.001 |
Medium (5–9) | 5.6 | 3.89 | 8.08 | <0.001 |
High (>9) | 5.88 | 4.18 | 8.28 | <0.001 |
Drugs | 1 | |||
None | ||||
NSAIDs | 1.18 | 0.86 | 1.61 | 0.31 |
DMARDs | 1 | 0.67 | 1.48 | 0.99 |
Steroids | 1.43 | 0.99 | 2.06 | 0.06 |
Initial arthritis duration | ||||
Damaged | 1.06 per decade | 0.92 | 1.22 | 0.39 |
Undamaged | 1.54 per decade | 1.22 | 1.96 | <0.001 |